Eliglustat hemitartrate
CAS: 928659-70-5
Ref. 3D-DMB65970
5mg | 272,00 € | ||
10mg | 426,00 € | ||
25mg | 710,00 € | ||
50mg | 993,00 € | ||
100mg | 1.275,00 € |
Información del producto
- Octanamide, N-[(1R,2R)-2-(2,3-dihydro-1,4-benzodioxin-6-yl)-2-hydroxy-1-(1-pyrrolidinylmethyl)ethyl]-, (2R,3R)-2,3-dihydroxybutanedioate (2:1)
- Eliglustat tartrate
- Genz 112638
Eliglustat hemitartrate is a drug that inhibits the enzyme glucosylceramide synthase, which is involved in the production of glucosylceramide. Eliglustat hemitartrate is used to treat Gaucher disease, a rare genetic disorder where fatty substances accumulate in the liver and spleen. Eliglustat hemitartrate has been shown to reduce the levels of glucosylceramide in patients with Gaucher disease and may be an effective treatment for this condition. It also has been shown to inhibit P-glycoprotein (P-gp), which may allow more eliglustat to enter cells.
Propiedades químicas
Consulta técnica sobre: 3D-DMB65970 Eliglustat hemitartrate
Si desea solicitar un presupuesto o realizar un pedido, por favor añada los productos deseados a su carrito y solicite un presupuesto o pedido desde el carrito. Es más rápido, más barato, y podrá beneficiarse de los descuentos y las ventajas disponibles.